Fund Holdings — DIADEMA PARTNERS LP

Total Portfolio Value:
$160.85M
Total Bought:
$83.27M
Total Sold:
$47.85M
Net Transaction:
+$35.42M
Notable People:
Timothy Beau Bassett
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Soleno Therapeutics Inc93,002284,152+191,150$6.64M$23.81M14.80%+$17.16M
Amgen Inc.(AMGN)052,100+52,100$0$14.55M9.04%+$14.55M
TG Therapeutics, Inc.(TGTX)207,883371,448+163,565$8.20M$13.37M8.31%+$5.17M
Neurocrine Biosciences, Inc.(NBIX)62,24794,042+31,795$6.88M$11.82M7.35%+$4.94M
Eli Lilly and Company(LLY)19,30214,816-4,486$15.94M$11.55M7.18%-$4.39M
Jazz Pharmaceuticals plcSHS USD(JAZZ)87,189104,473+17,284$10.82M$11.09M6.89%+$262.2K
BioMarin Pharmaceutical Inc.(BMRN)52,877192,877+140,000$3.74M$10.60M6.59%+$6.86M
Vaxcyte, Inc.(PCVX)92,385198,285+105,900$3.49M$6.45M4.01%+$2.96M
Viking Therapeutics, Inc.(VKTX)104,121197,468+93,347$2.51M$5.23M3.25%+$2.72M
Vertex Pharmaceuticals Incorporated(VRTX)010,000+10,000$0$4.45M2.77%+$4.45M
Protagonist Therapeutics Inc076,185+76,185$0$4.21M2.62%+$4.21M
Gilead Sciences, Inc.(GILD)030,000+30,000$0$3.33M2.07%+$3.33M
argenx SEADR(ARGX)12,2795,974-6,305$7.18M$3.29M2.05%-$3.89M
Immunocore Holdings plcADS(IMCR)96,984104,384+7,400$2.88M$3.28M2.04%+$398.1K
Regeneron Pharmaceuticals, Inc.(REGN)29,8285,607-24,221$18.92M$2.94M1.83%-$15.97M
Revolution Medicines, Inc.(RVMD)079,079+79,079$0$2.91M1.81%+$2.91M
Cogent Biosciences, Inc.(COGT)392,213392,2130$2.35M$2.82M1.75%+$466.7K
Scholar Rock Holding Corporation(SRRK)57,92362,926+5,003$1.86M$2.23M1.39%+$366.6K
Iteos Therapeutics Inc0206,200+206,200$0$2.06M1.28%+$2.06M
UroGen Pharma Ltd.(URGN)76,220150,000+73,780$843.0K$2.06M1.28%+$1.21M
Ultragenyx Pharmaceutical Inc.(RARE)053,985+53,985$0$1.96M1.22%+$1.96M
Viridian Therapeutics, Inc.(VRDN)162,063122,061-40,002$2.18M$1.71M1.06%-$478.2K
Merck & Co., Inc.(MRK)020,000+20,000$0$1.58M0.98%+$1.58M
Pacira BioSciences, Inc.(PCRX)38,92658,926+20,000$967.3K$1.41M0.88%+$441.0K
Olema Pharmaceuticals, Inc.(OLMA)100,000253,657+153,657$376.0K$1.08M0.67%+$704.6K
Reviva Pharmaceutcls Hldgs I650,7232,735,457+2,084,734$620.7K$1.04M0.65%+$421.8K
Mind Medicine Mindmed Inc0158,536+158,536$0$1.03M0.64%+$1.03M
Trevi Therapeutics, Inc.(TRVI)180,000185,830+5,830$1.13M$1.02M0.63%-$115.7K
Terns Pharmaceuticals Inc56,098259,852+203,754$154.8K$969.2K0.60%+$814.4K
89bio Inc231,43698,382-133,054$1.68M$966.1K0.60%-$716.4K
Climb Bio, Inc.(CLYM)669,803702,135+32,332$817.2K$870.6K0.54%+$53.5K
Scpharmaceuticals Inc0217,623+217,623$0$829.1K0.52%+$829.1K
Vistagen Therapeutics, Inc.(VTGN)565,975403,922-162,053$1.41M$807.8K0.50%-$607.1K
Arvinas, Inc.(ARVN)096,455+96,455$0$709.9K0.44%+$709.9K
Apogee Therapeutics Inc40,00010,572-29,428$1.49M$459.1K0.29%-$1.04M
Phathom Pharmaceuticals, Inc.(PHAT)040,294+40,294$0$386.4K0.24%+$386.4K
Nuvalent Inc05,000+5,000$0$381.5K0.24%+$381.5K
Alector Inc456,546266,023-190,523$561.6K$372.4K0.23%-$189.1K
Proqr Thrapeutics N VSHS EURO
SHS EURO
207,694157,694-50,000$276.2K$321.7K0.20%+$45.5K
Replimune Group, Inc.(REPL)74,53032,483-42,047$726.7K$301.8K0.19%-$424.9K
Eledon Pharmaceuticals, Inc.(ELDN)64,61364,6130$219.0K$175.1K0.11%-$43.9K
Relay Therapeutics, Inc.(RLAY)426,34643,616-382,730$1.12M$150.9K0.09%-$966.1K
Elevation Oncology Inc0362,935+362,935$0$133.2K0.08%+$133.2K
PureTech Health plcADS(PRTCY)07,324+7,324$0$126.3K0.08%+$126.3K
Summit Therapeutics Inc.(SMMT)0932+932$0$19.8K0.01%+$19.8K
Zai Lab LimitedADR(ZLAB)03,785+3,785$0$13.2K0.01%+$13.2K
Alnylam Pharmaceuticals, Inc.(ALNY)13,1150-13,115$3.54M$0—-$3.54M
Ascendis Pharma A/SADR(ASND)8,3210-8,321$1.30M$0—-$1.30M
Candel Therapeutics, Inc.(CADL)25,0450-25,045$141.5K$0—-$141.5K
Centessa Pharmaceuticals PlcADS164,0480-164,048$2.36M$0—-$2.36M
Cytokinetics, Incorporated(CYTK)20,0000-20,000$803.8K$0—-$803.8K
Gossamer Bio, Inc.(GOSS)269,5890-269,589$296.5K$0—-$296.5K
Kalvista Pharmaceuticals Inc135,5090-135,509$1.56M$0—-$1.56M
Mereo BioPharma Group plcADS(MREO)492,2150-492,215$168.5K$0—-$168.5K
Novo Nordisk A/SADR(NVO)24,6180-24,618$1.68M$0—-$1.68M
Rhythm Pharmaceuticals, Inc.(RYTM)50,0000-50,000$2.65M$0—-$2.65M
Sage Therapeutics Inc183,4660-183,466$1.46M$0—-$1.46M
Sagimet Biosciences Inc.COM SER A(SGMT)46,0190-46,019$150.0K$0—-$150.0K
Springworks Therapeutics Inc60,0000-60,000$2.65M$0—-$2.65M
uniQure N.V.SHS(QURE)36,5000-36,500$386.9K$0—-$386.9K
Page 1 of 1
DIADEMA PARTNERS LP — 13F Holdings — Q2 2025 | TickerTrail